TopAlliance Biosciences, Inc. is committed to the development of innovative therapies for patients in the communities we serve, including our employees, and to preserve the environment we operate in. We believe in remaining true to the inspirations that have driven the success of our company and will continue to let science and pragmatism drive our objectives in finding cures for patients.
“Expanded Access” refers to the use of an investigational product outside of a clinical trial for potential treatment of patients. The US Food and Drug Administration has set forth criteria for when use of an investigational drug is permitted under the provisions of expanded access. They include all of the following:
You may reference information about our pipeline and ongoing clinical trials by accessing http://www.topalliancebio.com/ or https://www.clinicaltrials.gov.